Treatment of circadian rhythm disorders
Use of an effective amount of tasimelteon to treat or entrain a light perception impaired patient suffering from Non-24 hour disorder. A medicament containing Tasimelteon is used to entrain the patient to a 24 hour sleep-wake cycle in which the patient awakens at or near a target wake time following...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Use of an effective amount of tasimelteon to treat or entrain a light perception impaired patient suffering from Non-24 hour disorder. A medicament containing Tasimelteon is used to entrain the patient to a 24 hour sleep-wake cycle in which the patient awakens at or near a target wake time following a daily sleep period of approximately 7 to 9 hours, and maintaining this 24 hour sleep-wake cycle. The medicament is formulated for oral administration of 20 -50 mg of tasimelteon once daily to the patient 0.5 to 1.5 hours before a target bedtime. |
---|